LINEAGE CELL THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [●], 20__ Debt SecuritiesIndenture • March 11th, 2021 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Indenture, dated as of [●], 20__, among Lineage Cell Therapeutics, Inc., a California corporation (the “Company”), and [Trustee], as trustee (the “Trustee”):
Lineage Cell Therapeutics, Inc. and ________, As Warrant Agent Form of Common Share Warrant Agreement Dated as of _____________Common Share Warrant Agreement • March 11th, 2021 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
This Common Share Warrant Agreement (this “Agreement”), dated as of __________between Lineage Cell Therapeutics, Inc., a California corporation (the “Company”) and _________, a [corporation] [national banking association] organized and existing under the laws of __________ and having a corporate trust office in ________ , as warrant agent (the “Warrant Agent”).
